James Schaub is EVP and COO of RVL Pharmaceuticals plc. Currently has a direct ownership of 524,835 shares of RVLP, which is worth approximately $0. The most recent transaction as insider was on May 18, 2023, when has been sold 5,577 shares (Ordinary Shares) at a price of $0.87 per share, resulting in proceeds of $4,851. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 525K
0% 3M change
0% 12M change
Total Value Held $0

James Schaub Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 18 2023
SELL
Payment of exercise price or tax liability
$4,851 $0.87 p/Share
5,577 Reduced 1.05%
524,835 Ordinary Shares
Jan 24 2023
SELL
Payment of exercise price or tax liability
$12,106 $1.26 p/Share
9,608 Reduced 1.78%
530,412 Ordinary Shares
Aug 08 2022
BUY
Open market or private purchase
$232,500 $1.55 p/Share
150,000 Added 21.74%
540,020 Ordinary Shares
May 18 2022
SELL
Payment of exercise price or tax liability
$8,782 $1.4 p/Share
6,273 Reduced 1.58%
390,020 Ordinary Shares
Jan 24 2022
SELL
Payment of exercise price or tax liability
$10,856 $1.13 p/Share
9,607 Reduced 2.37%
396,293 Ordinary Shares
Dec 16 2021
BUY
Open market or private purchase
$100,366 $1.07 p/Share
93,800 Added 18.77%
405,900 Ordinary Shares
May 18 2021
SELL
Payment of exercise price or tax liability
$20,658 $3.12 p/Share
6,621 Reduced 2.08%
312,100 Ordinary Shares
Jan 24 2021
SELL
Payment of exercise price or tax liability
$43,204 $4.46 p/Share
9,687 Reduced 2.95%
318,721 Ordinary Shares
JS

James Schaub

EVP and COO
Bridgewater, NJ

Track Institutional and Insider Activities on RVLP

Follow RVL Pharmaceuticals plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RVLP shares.

Notify only if

Insider Trading

Get notified when an Rvl Pharmaceuticals PLC insider buys or sells RVLP shares.

Notify only if

News

Receive news related to RVL Pharmaceuticals plc

Track Activities on RVLP